兩家獨立企業由此誕生
生命科學與診斷 & 分析和企業服務
Well format: 384-well
| Description | Specification |
|---|---|
| Number of Rows | 16 |
| Number of Columns | 24 |
| Well volume | 105 µL |
| Recommended working volume | 24 µL- 90 µL |
| Height (mm) | 14.35 |
| Length (mm) | 127.76 |
| Width (mm) | 85.48 |
| Well diameter (mm) | 3.65 |
| Well depth (mm) | 10.4 |
| A1 to top offset (mm) | 9.0 |
| A1 to side offset (mm) | 12.10 |
| Well-to-well spacing (mm) | 4.50 |
| Volume | 105 μL |
| 自動化兼容 | Yes |
|---|---|
| 塗層處理 | Untreated |
| 顏色 | Gray |
| 檢測方法 | Luminescence, Alpha |
| Format | Microplates |
| 材料 | Polystyrene |
| 產品品牌名稱 | AlphaPlate |
| 運輸條件 | 環境 |
| Sterile | No |
| 產品尺寸 | Case of 50 |
| 體積 | 105 µL |
| 阱數量 | 384 well plate |
Evaluating pharmaceutical compound efficacy and safety in regulating cell behavior can involve the study of multiple signal transduction pathways and measuring more than one cellular target can provide greater confidence of positive compound hits on the cellular target of interest. Protein phosph ...
While fundamental knowledge about tumor immunology has exploded recently, a new therapeutic approach to cancer is taking off: immunotherapy. Instead of directly attacking tumor cells, the idea is to help the immune system recognize and destroy them.
The use of CAR-T cells (Chimeric Antigen ...
Technical advancements in antibody engineering has brought about greater interest in more novel antibody therapeutic design and the emergence of new classes of antibody therapeutics called bispecific antibodies (bsAbs). The principle behind bispecific antibody design is to create an antibody / an ...
It has been suggested that inflammation promotes malignancy via proinflammatory cytokines, such as IL-1ß, which enhance immune suppression through the induction of myeloid suppressor cells (MSC), thereby counteracting immune surveillance and allowing the outgrowth and proliferation of malignant c ...
When PD-1, which is expressed on the T cell, binds to PD-L1 expressed on the tumor cell, the T cell response is suppressed. Utilization of this pathway leads to tumor immune escape and promotes tumor cell growth. In fact, PD-L1 expression increases with tumor severity in many types of cancer. Rel ...
The main vectors of gene therapy in research are viruses. The most popular tool for gene delivery is a genetically modified lentivirus. Modified lentivirus (HIV-1) vectors retain their ability to infect undivided cells, thereby increasing their ability to transduce a wide variety of cells, includ ...
A variety of chemotherapeutic drugs with different modes of action have been developed and tested as potential therapies for colorectal cancer. Characterizing the effects of potential drugs with different modes of action is a key part of the process.
In this application note you will learn: ...
Tumor Necrosis Factors (TNFs) are cytokines that are the primary modifiers of inflammatory and immune response. Researchers have shown that a soluble form of TNFR1 (sTNFR1) is a truncated version of the receptor produced by the disintegration and extracellular release of membranous protein on the ...
Binding events between biomolecules are important components of biological processes and a number of these biomolecular interactions have been targeted for the development of novel therapeutic drugs. p53 is a transcription factor and tumor suppressor protein that is activated in response to cellu ...
